Relación entre la pureza radioquímica del 123i-ioflupano y la captación extracraneal (tiroidea y parotídea)

  1. Lucía Díaz Platas
  2. Stefan Prado Wohlwend
  3. Mónica Romero Otero
  4. Alba Iniesta Medel
  5. Luis Ramudo Cela
Revista:
Ars pharmaceutica

ISSN: 2340-9894,  0004-2927

Ano de publicación: 2015

Volume: 56

Número: 4

Páxinas: 225-230

Tipo: Artigo

DOI: 10.4321/S2340-98942015000400006 DIALNET GOOGLE SCHOLAR lock_openAcceso aberto editor

Outras publicacións en: Ars pharmaceutica

Resumo

Aim: The aim of this study is to see the effect of radiochemical purity (PR) of 123I- Ioflupane used for cerebral dopamine transporter SPECT (Single Photon Emission Computed Tomography) on the images and evaluate the possible influence of extravasation during the administration in patient with Parkinson syndrome. Material and methods: A Prospective study was performed in 39 patients. The PR of 123I-Ioflupane was determined by radiochromatography. The regions of interest (ROI) were defined in general area of the brain, parotid and cervical region, obtaining the average counts in each region and activity ratios thyroid / brain (RTC) and parotid / brain (RPC). It was proposed a model of multiple linear regression with quantitative and categorical predictors Results: The model showed that correlation between the PR and the RTC was modified by the presence of extravasation, it was statistically significant (p < 0.001) and predicted the 42.31 % of the variability of the RTC. The correlation between PR and PRC was not modified by any of the variables proposed. The model was statistically significant (p < 0.0176) and 12.3% predicted variability RPC. Conclusions: The predictive variability of the model of RTC is acceptable and explains the negative impact of extravasation. However, the ability to explain the variability of the PRC is low and should not be attributed to variables studied. A low PR and extravasation during the administration of the radiopharmaceutical involves worse quality of image and increased thyroid irradiation.

Referencias bibliográficas

  • Bajaj, N, Hauser, RA, Seibyl, J, Kupsch, A, Plotkin, M, Chen, C, Grachev, ID. (2014). Association between Hoehn and Yahr, Mini-Mental State. Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I123 injection (DaTSCAN™) in subjects with clinically uncertain parkinsonian syndromes. Alzheimers Res Ther.. 6.
  • Ezz Eddin, MH, Díaz Platas, L, Moreno Frigols, JL. (2013). Comparación de algunos métodos para el control de calidad del 123I-Ioflupano. Ars Pharm.. 54. 48-51
  • Menéndez-González, M, Tavares, F, Zeidan, N, Salas-Pacheco, JM, Arias-Carrión, O. (2014). Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study. Front Aging Neurosci.. 6.
  • Ficha técnica Ioflupano 123I. Ge Healthcare LimitedAgencia Española de medicamentos y producto sanitarios.
  • Tavares, AS, Batis, JC, Papin, C, Jennings, D, Alagille, D, Russell, DS, Vala, C, Lee, H, Baldwin, RM, Zubal, IG, Marek, KL, Seibyl, JP, Barret, O, Tamagnan, GD. (2013). Kinetic Modeling, Test-Retest, and Dosimetry of 123I-MNI-420 in Humans. J Nucl Med.. 54. 1760-1767
  • Ficha técnica de Ioduro (123I) de sodio. MallinckrodtAgencia Española de medicamentos y producto sanitarios.
  • Doménech, JM, Navarro, JB. (2014). Regresión múltiple con predictores categóricos y cuantitativos. 7. Signo. Barcelona.
Fonte de datos: Dialnet